Article Details

Q2 2021 EPS Estimates for Pluristem Therapeutics Inc. (NASDAQ:PSTI) Decreased by Analyst

Retrieved on: 2020-12-13 23:48:45

Tags for this article:

Click the tags to see associated articles and topics

Q2 2021 EPS Estimates for Pluristem Therapeutics Inc. (NASDAQ:PSTI) Decreased by Analyst. View article details on hiswai:

Excerpt

Jefferies Financial Group analyst C. Howerton now anticipates that the <b>biotechnology</b> company will post earnings of ($0.30) per share for the quarter, ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up